• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Edwards Lifesciences

Edwards Lifesciences

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Transcatheter Mitral Valve Replacement (TMVR) Market - Analysis, Trends & Forecasts to 2025 - Research and Markets

    Global Transcatheter Mitral Valve Replacement (TMVR) Market - Analysis, Trends & Forecasts to 2025 - Research and Markets

  2. European Market Report for Port Needles 2017 - MedCore - Research and Markets

    European Market Report for Port Needles 2017 - MedCore - Research and Markets

  3. A Contrarian Bent

    Disciplined Growth Investors’ managers have built a moderate allocation strategy unlike most others.

  4. 2014's Biggest Stock Winners: Is There Any Gas Left in the Tank?

    Declining fuel prices stoked great returns at several of these companies, but that's not a lasting advantage.

  5. Which Funds Own My Stock?

    Ownership data provide a look at who else owns the company.

  6. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

  7. Home Prices Keep Falling

    The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.